首页> 美国卫生研究院文献>other >Presentation of Antibacterial and Therapeutic Anti-inflammatory Potentials to Hydroxyapatite via Biomimetic With Azadirachta indica: An in vitro Anti-inflammatory Assessment in Contradiction of LPS-Induced Stress in RAW 264.7 Cells
【2h】

Presentation of Antibacterial and Therapeutic Anti-inflammatory Potentials to Hydroxyapatite via Biomimetic With Azadirachta indica: An in vitro Anti-inflammatory Assessment in Contradiction of LPS-Induced Stress in RAW 264.7 Cells

机译:通过仿生印A与仿制药对羟基磷灰石的抗菌和治疗性抗炎潜力的介绍:体外抗炎评估与LPS诱导的RAW 264.7细胞应激的矛盾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

In the present study, for the first time, biomimetization of hydroxyapatite (HA) with Azadirachta indica (AI) was proposed and established its antioxidant, antibacterial, and anti-inflammatory potential on lipopolysaccharide (LPS). The ethanolic extract of AI was found rich with phenolics and flavonoids, and determined their concentration as 8.98 ± 1.41 mg gallic acid equivalents/g and 5.46 ± 0.84 mg catechin equivalents/g, respectively. The HA was prepared by sol-gel method from calcium nitrate tetrahydrate and orthophosphoric acid, and successfully biomimetization was performed with ethanolic extract of AI. The FTIR analysis settled that as-synthesized HA-AI composite was comprised of both HA and AI. The XRD pattern and Zeta potential revealed that the HA-AI composite was crystalline and negative in charge (−24.0 mV). The average-size distribution, shape, and size of the HA-AI composite was determined as 238.90 d.nm, spherical, and 117.90 nm from size distribution, SEM, and HR-TEM analysis, respectively. The SEM-EDX concluded that the HA-AI composite was comprised of elements of HA as well as AI. The HA-AI composite presented potential antioxidant activity and its EC50 values (dose required to inhibit about half of the radicals) for ABTS and DPPH assays were determined as 115.72 ± 2.33 and 128.51 ± 1.04 μg/ml, respectively. The HA-AI composite showed potent antibacterial activity, and minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) towards S. aureus (ATCC 700699) and E. coli (ATCC 10536) were correspondingly determined as 266.7 ± 28.87 and 600.0 ± 50.0 μg/ml, and 400.0 ± 86.6 and 816.7 ± 76.38 μg/ml. Most importantly, HA-AI composite presented the potential anti-inflammatory response toward lipopolysaccharide (LPS) in RAW 264.7 cells. The dose of 250 μg/ml of HA-AI composite has shown optimum protection against LPS-induced stress (1 μg/ml) by scavenging oxidants and regulating mitochondrial membrane potential (MMP), inflammatory and apoptotic factors. Thus, this study concluded that the impartation of potential biofunctional features to HA from plant sources through biomimetic approach is much beneficial and could find potential application in dentistry and orthopedic.
机译:在本研究中,首次提出了用印度印A(Azadirachta indica(AI))对羟基磷灰石(HA)进行生物仿制,并确立了其对脂多糖(LPS)的抗氧化,抗菌和抗炎潜力。发现AI的乙醇提取物富含酚类和类黄酮,其浓度分别为8.98±1.41 mg没食子酸当量/ g和5.46±0.84 mg儿茶素当量/ g。用四水合硝酸钙和正磷酸通过溶胶-凝胶法制备HA,并用AI的乙醇提取物成功进行了仿生。 FTIR分析确定合成后的HA-AI复合材料同时包含HA和AI。 XRD图谱和Zeta电势表明,HA-AI复合物为晶体且带负电(-24.0 mV)。根据尺寸分布,SEM和HR-TEM分析,确定HA-AI复合材料的平均尺寸分​​布,形状和尺寸分别为238.90 d.nm,球形和117.90 nm。 SEM-EDX得出结论,HA-AI复合材料由HA以及AI组成。 HA-AI复合材料具有潜在的抗氧化活性,其ABTS和DPPH分析的EC50值(抑制大约一半自由基所需的剂量)分别确定为115.72±2.33和128.51±1.04μg/ ml。 HA-AI复合材料显示出强大的抗菌活性,对金黄色葡萄球菌(ATCC 700699)和大肠杆菌(ATCC 10536)的最小抑菌浓度(MIC)和最小杀菌浓度(MBC)分别确定为266.7±28.87和600.0± 50.0μg/ ml,和400.0±86.6和816.7±76.38μg/ ml。最重要的是,HA-AI复合材料在RAW 264.7细胞中表现出对脂多糖(LPS)的潜在抗炎反应。通过清除氧化剂并调节线粒体膜电位(MMP),炎性和凋亡因子,250μg/ ml的HA-AI复合物剂量已显示出对LPS诱导的应激的最佳保护作用(1μg/ ml)。因此,这项研究得出的结论是,通过仿生方法将潜在的生物功能特征从植物来源赋予HA十分有益,并且可以在牙科和整形外科中找到潜在的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号